LEFT VENTRICULAR THROMBUS
Clinical trials for LEFT VENTRICULAR THROMBUS explained in plain language.
Never miss a new study
Get alerted when new LEFT VENTRICULAR THROMBUS trials appear
Sign up with your email to follow new studies for LEFT VENTRICULAR THROMBUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart clot showdown: could a simpler blood thinner replace warfarin?
Disease control Recruiting nowThis trial tests whether apixaban, a newer blood thinner with fixed dosing, works as well as warfarin for dissolving dangerous blood clots in the heart's main pumping chamber. Adults with a confirmed left ventricular thrombus are randomly assigned to receive either apixaban or wa…
Matched conditions: LEFT VENTRICULAR THROMBUS
Phase: PHASE3 • Sponsor: University of Arizona • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New hope for heart attack patients: can a common blood thinner prevent strokes?
Disease control Recruiting nowThis study tests whether adding the blood thinner rivaroxaban (Xarelto) to standard care helps dissolve dangerous blood clots in the heart after a major heart attack. Researchers will track 320 participants to see if the drug reduces strokes and other complications. The goal is t…
Matched conditions: LEFT VENTRICULAR THROMBUS
Phase: NA • Sponsor: Jilin University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Heart clot registry aims to prevent strokes in thousands
Knowledge-focused Recruiting nowThis study is tracking 1,500 people who either have a blood clot in the heart's main pumping chamber (left ventricular thrombus) or are at high risk for one. Researchers will collect blood samples, scan results, and quality-of-life data over 12 months to learn why clots form and …
Matched conditions: LEFT VENTRICULAR THROMBUS
Sponsor: Queen Mary University of London • Aim: Knowledge-focused
Last updated Jul 18, 2026 00:00 UTC